HUAWEI HENGYUAN
Huawei Hengyuan is a biomedical technology company dedicated to the preparation of Sertoli cells (with immune immunity) in vitro using cell reprogramming technology, mainly for: autoimmune diseases (such as rheumatoid arthritis); reproductive adjuvant therapy; human body Chronic diseases (such as Parkinson's); organ/tissue colonization (such as skin allograft).
HUAWEI HENGYUAN
Industry:
Biotechnology Health Care Medical
Founded:
2018-12-01
Address:
Beijing, Beijing, China
Country:
China
Total Employee:
11+
Status:
Active
Total Funding:
0
Similar Organizations
Qinghui Liannuo
Qinghui Liannuo is a biotechnology company engaged in the development of innovative immunological drugs.
Investors List
Tsing Ventures
Tsing Ventures investment in Seed Round - Huawei Hengyuan
More informations about "Huawei Hengyuan"
Huawei Hengyuan - Funding, Financials, Valuation & Investors
Huawei Hengyuan is a biomedical technology company dedicated to the preparation of Sertoli cells. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. โฆSee details»
Huawei Hengyuan - Products, Competitors, Financials, Employees ...
Huawei Hengyuan. Frequently Asked Questions (FAQ). When was Huawei Hengyuan founded? Huawei Hengyuan was founded in 2018. Where is Huawei Hengyuan's headquarters? Huawei โฆSee details»
Huawei Hengyuan - Company Profile - Tracxn
Huawei Hengyuan - Developer of human immune cell-derived therapies for multiple disorders. Raised funding from 1 investor. Huawei Hengyuan has 3111 competitors.See details»
Huawei Hengyuan completed tens of millions of Pre-A+ round โฆ
Huawei Hengyuan is a biomedical technology enterprise, dedicated to using cell reprogramming technology to prepare Sertoli cells (with immune immunity function) in vitro, mainly used in: โฆSee details»
Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd.
Explore Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Endocrinology ...See details»
Huawei Hengyuan - Drug pipelines, Patents, Clinical trials - Synapse
Oct 3, 2024 Explore Huawei Hengyuan with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Immune System Diseases, Endocrinology and Metabolic Disease, โฆSee details»
Huawei Hengyuan - Updates, News, Events, Signals & Triggers
Huawei Hengyuan is a biomedical technology company dedicated to the preparation of Sertoli cellsSee details»
Huawei Hengyuan - Raised Funding from 1 investor - Tracxn
Mar 15, 2025 Huawei Hengyuan; has 1 institutional investor - Unity Ventures.View all Huawei Hengyuan Investors. View all funding & investor details of Huawei Hengyuan. Our Lite Plan โฆSee details»
Huawei Hengyuan Biomedical Technology Co., Ltd. (Huawei โฆ
ไบ่งฃHuawei Hengyuan Biomedical Technology Co., Ltd. (Huawei Hengyuan Biomedical Technology Co., Ltd.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็17็ฏๆฐ้ป๏ผ็พ็ ้ขๅ: โฆSee details»
Huawei Hengyuan - Crunchbase
Huawei Hengyuan is a biomedical technology company dedicated to the preparation of Sertoli cellsSee details»
raSC-1 - Drug Targets, Indications, Patents - Synapse - Patsnap
RaSC-1, Initially developed by Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune System Diseases,Skin โฆSee details»
Huawei Organizational Structure | Types And Importance
Jan 21, 2023 Changing culture โ Huawei is a broad cultured, future-obsessed, change-obsessed organization. The company was future and change-obsessed to such a degree since its โฆSee details»
Corporate Information - Huawei
Huawei was named the world's top patent applicant the second year in a row according to the World Intellectual Property Organization, submitting 3,898 patent applications. Huawei's LTE networks covered more than 140 capital cities and โฆSee details»
Everlife Biomed (ๅๅซๆๆบ) - Tech in Asia
Huawei Hengyuan (ๅๅซๆๆบ) is a biomedical research and development company. Report. AD. Remove this ad space by subscribing. The company isn't hiring currently. But don't let it stop you.See details»
Corporate Governance - Huawei
Huawei stays customer-centric, inspires dedication, continuously improves its governance structure, organizations, processes, and appraisal systems ... is the organization through โฆSee details»
Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd.
ไบ่งฃHuawei Hengyuan (Beijing) Biomedical Technology Co., Ltd. (ๅๅซๆๆบ๏ผๅไบฌ๏ผ็็ฉๅป่ฏ็งๆๆ้ๅ ฌๅธ)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็๏ผ็พ็ ้ขๅ:ๅ ็ซ็ณป็ป็พ็ ๏ผๅ ๅ โฆSee details»
Company Facts - Huawei
By the end of 2023, Huawei held a total of 140,000+ active patents and had signed over 200 patent licensing and cross-license agreements with many of the worldโs largest patent holders. โฆSee details»
Huawei corruption scandal: Police search European Parliament
2 days ago One of the officials confirmed the search in Strasbourg was part of the investigation into Huawei's lobbying practices. Advertisement Parliament members and their assistants โฆSee details»
Li Hongyuan incident - Wikipedia
Li Hongyuan joined Huawei's Hangzhou branch in October 2005 after he left Zhejiang Juhua Co., Ltd., a chemical industry company in Quzhou, China.Huawei dismissed him in 2017 by โฆSee details»
Belgian prosecutors probe whether Huawei paid for letter
3 days ago Conservative Italian lawmaker Fulvio Martusciello, one of the signatories, posted the pro-Huawei letter on X on Feb. 15, 2021, but later deleted it. His former parliamentary adviser โฆSee details»